Literature DB >> 10675868

Oculographic and clinical characterization of thirty-seven children with anomalous head postures, nystagmus, and strabismus: the basis of a clinical algorithm.

R W Hertle1, X Zhu.   

Abstract

BACKGROUND AND
PURPOSE: We studied children with nystagmus who also had anomalous head postures and strabismus to determine the etiology of the conditions and present a diagnostic clinical algorithm.
METHODS: The patients for this study were among the 560 patients evaluated in the ocular motor neurophysiology laboratory between the years 1991 and 1997. Clinical characteristics, infrared oculography data, and medical and surgical treatments were entered into a database for analysis. Oculography was performed on all patients according to a standard protocol, and data were stored and analyzed off-line. Etiology of anomalous head posture was determined with both clinical and oculography information.
RESULTS: Thirty-seven children are the subjects of this report. The etiology of anomalous head posture was a "gaze null" due to congenital nystagmus in 23 (62%) patients, an "adduction null" due to manifest latent nystagmus in 12 (32%) patients, spasmus nutans in 1 (3%) patient, and strabismus in 1 (3%) patient. The patients' ages ranged from 9 months to 12 years and averaged 4.4 years. Sixty-nine percent were male patients. Nineteen (63%) of 30 patients had abnormal recognition (linear optotype) acuity in at least 1 eye on monocular cover; the recognition remained abnormal in 5 (17%) of 30 patients under binocular conditions. Thirty percent of patients had amblyopia, 16% had some structural disease of the eyes, 22% had some systemic syndrome or abnormality, 57% had a significant refractive error, and 27% had some ability to fuse.
CONCLUSIONS: The major etiology for anomalous head posture in these patients was to adopt a gaze null due to congenital nystagmus (62% of patients) regardless of the direction of their anomalous head posture or type of strabismus. Moving the fixing eye as the first step for the anomalous head posture, combined with moving the nonfixing eye for the resulting strabismus may help treat these patients.

Entities:  

Mesh:

Year:  2000        PMID: 10675868     DOI: 10.1016/s1091-8531(00)90008-9

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  9 in total

1.  Changes in astigmatism in children with congenital nystagmus.

Authors:  J Jethani; K Prakash; P Vijayalakshmi; S Parija
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-12-16       Impact factor: 3.117

2.  Anomalous head posture related to visual problems.

Authors:  Paolo Nucci; Batya Curiel; Andrea Lembo; Massimiliano Serafino
Journal:  Int Ophthalmol       Date:  2014-04-10       Impact factor: 2.031

3.  SPASMUS NUTANS.

Authors:  T S Raghuraman; K M Shukla
Journal:  Med J Armed Forces India       Date:  2011-07-21

4.  A 25-month-old girl with vision loss, nystagmus, and anomalous head posture.

Authors:  Joel Metzger; Richard Hertle; John Avallone; Edward Cheeseman
Journal:  Digit J Ophthalmol       Date:  2009-02-23

Review 5.  Nystagmus.

Authors:  J S Stahl; R J Leigh
Journal:  Curr Neurol Neurosci Rep       Date:  2001-09       Impact factor: 5.081

Review 6.  Epidemiology and management of essential tremor in children.

Authors:  Joseph Ferrara; Joseph Jankovic
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

7.  Surgical interventions for infantile nystagmus syndrome.

Authors:  Kwang M Cham; Larry A Abel; Ljoudmila Busija; Lionel Kowal; Anat Bachar Zipori; Laura E Downie
Journal:  Cochrane Database Syst Rev       Date:  2021-02-18

8.  Albinism: particular attention to the ocular motor system.

Authors:  Richard W Hertle
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Jul-Sep

9.  Effects of extraocular muscle surgery in children with monocular blindness and bilateral nystagmus.

Authors:  Veit Sturm; Marketa Hejcmanova; Klara Landau
Journal:  BMC Ophthalmol       Date:  2014-11-20       Impact factor: 2.209

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.